Smoking: Clinical Trials

35 trials for Smoking, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

22 completed, 5 recruiting, 4 unknown, 2 active not recruiting. 35 Early Phase 1.

By phase and status

PhaseTrialsStatus
Early Phase 135Completed 22, Recruiting 5, Unknown 4, Active not recruiting 2, Not yet recruiting 1, Withdrawn 1

Follow Smoking: new trials by email Literature Review of Smoking trials Research Report on Smoking

Trials (filtered) newest first · largest first

All 35 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Lung Health and Breath Biomarkers: Acute Effects of Inhaled Cannabis
Cannabis (THC), Tobacco Cigarette - Cannabis Use, Tobacco
Early Phase 1Not yet recruitingHannah Harris122026-12-012026-11-04
Testing the ETM: Examination and Comparison of Different Methods
Reat ETM, Hypothetical ETM - Cigarette Smoking
Early Phase 1CompletedVirginia Polytechnic Institute and State University872024-12-022026-06-05
Role of Inflammation in Vascular Phenotype Associated With E-cigarette Use
Placebo, Salsalate 750 MG Oral Tablet [DISALCID] - Electronic Cigarette Use, Endothelial Dysfunction
Early Phase 1RecruitingUniversity of Iowa242024-08-152026-10-29
Sex Differences in the Vascular Effects of E-cigarette Use
Local heating + L-NAME (NG-nitro-L-arginine methyl ester; nitric oxide synthase inhibitor), Chronic estrogen exposure - E-cigarette Use
Early Phase 1RecruitingAnna Stanhewicz, PhD802023-12-022025-12-15
Electronic Cigarettes and Nicotine Pouches for Smoking Cessation
E-cigarettes device plus liquid, Nicotine Pouches, Basic care counseling about smoking cessation - Role of Tobacco Harm Reduction in Smoking Cessation, Efficiency and Efficacy of E-cigarettes and Nicotine Pouches
Early Phase 1UnknownAlternative Research Initiative6002023-12-012023-02-06
Evaluation of the Electronic Cigarette Withdrawal Syndrome
Transdermal Nicotine Patch, Placebo Nicotine Patch - E-cigarette Use, Withdrawal
Early Phase 1RecruitingJohns Hopkins University1502023-11-282026-07-15
Nicotine and Pavlovian Bias
Nicotine, Placebo - Nicotine Vaping, Nicotine Dependence
Early Phase 1UnknownUniversity of Southern California402023-10-252023-11-09
Preloaded Combination Nicotine Replacement Therapy on Smoking Cessation of Adult Population in Kazakhstan
Nicotine patch, Nicotine gums, Brief Advice (5 A's & 5 R's), Nicotine Patch: Preloading for 4 weeks - Smoking Cessation, Smoking, Cigarette
Early Phase 1UnknownNazarbayev University2002023-07-012023-03-24
Cardiovascular Effects of Very Low Nicotine Content Cigarettes
SPECTRUM cigarettes, usual brand of Cigarettes - Tobacco Use
Early Phase 1RecruitingWake Forest University Health Sciences492023-04-042026-08-28
Feasibility of Treatment for Vaping Cessation
Varenicline, brief behavioral therapy - Vaping
Early Phase 1WithdrawnMayo Clinic2023-02-012023-02-08
The Effects of Sedatives on Tobacco Use Disorder Version 2
Ketamine, Midazolam, Dexmedetomidine - Tobacco Smoking
Early Phase 1CompletedWake Forest University Health Sciences202023-01-312026-04-01
Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health
Tobacco flavored liquid type 1, Tobacco flavored liquid type 2 - E-Cig Use
Early Phase 1CompletedVirginia Commonwealth University42022-01-102025-07-01
The Effect of Sweet Flavoring on the Rewarding and Reinforcing Value of Cigarillo Use Among Young Adults
Flavor - Tobacco Use, Cigar Smoking
Early Phase 1CompletedUniversity of Pennsylvania952021-09-142024-05-17
The Effects of IQOS Use on Cigarette Smoking Behaviors
IQOS - Smoking, Cigarette Smoking
Early Phase 1CompletedUniversity of Pennsylvania1022021-08-262025-02-03
Responses to E-Cigarette Advertising
Viewing e-cigarette ads - E-Cig Use
Early Phase 1CompletedUniversity of Massachusetts, Worcester622021-08-042023-09-08
Compensatory Behavior of E-cig Users in Response to Reduced Nicotine E-liquids
Lower nicotine e-liquid, Higher nicotine eliquid - Healthy, Nicotine Addiction
Early Phase 1CompletedRochester Institute of Technology722021-07-152024-09-27
Impact of Low Nicotine Cigarette Messaging on Perceptions and Cigarette Choices
Low Nicotine Content Cigarettes, Control message, Test message - Smoking, Cigarette
Early Phase 1CompletedMasonic Cancer Center, University of Minnesota642021-04-202024-02-26
A Study to Develop a Strategy to Increase Lung Cancer Screening in Women Who May Be at Risk for Lung Cancer
LungTalk - Smoking
Early Phase 1Active not recruitingMemorial Sloan Kettering Cancer Center302021-04-092026-05-06
Centralized Lung Cancer EARly Detection Among Smokers (CLEAR Study)
Best Practice, Nicotine Patch, Quality-of-Life Assessment - Smoking, Lung Cancer
Early Phase 1Active not recruitingM.D. Anderson Cancer Center3582020-07-312025-08-22
Isradipine Enhancement of Virtual Reality Cue Exposure for Smoking Cessation
Isradipine, Cue Exposure - Nicotine Dependence, Smoking, Cigarette
Early Phase 1CompletedJasper A. Smits782020-01-222026-06-15

Showing 20 of 35. Sign in to see all of them.

Narrower conditions

Vaping (12)  ·  Cigarette Smoking (8)  ·  Tobacco Use Disorder (7)  ·  Smoking Cessation (5)  ·  Tobacco Use (3)  ·  Alcohol Drinking (2)  ·  Behavior, Addictive (2)  ·  Marijuana Abuse (2)  ·  Pulmonary Disease, Chronic Obstructive (2)  ·  Tobacco Smoking (2)  ·  Alcoholism (1)  ·  Asthma (1)  ·  Cardiovascular Diseases (1)  ·  Cigar Smoking (1)

Broader conditions

Behavior (35)  ·  Chemically-Induced Disorders (10)  ·  Mental Disorders (10)  ·  Substance-Related Disorders (10)  ·  Tobacco Smoking (8)  ·  Tobacco Use (7)  ·  Health Behavior (5)  ·  Pathological Conditions, Signs and Symptoms (5)  ·  Lung Diseases (4)  ·  Pathologic Processes (4)  ·  Respiratory Tract Diseases (4)  ·  Disease Attributes (3)  ·  Lung Diseases, Obstructive (3)  ·  Chronic Disease (2)

Interventions

Tobacco Use Cessation Devices (4)  ·  Nicotine (3)  ·  Varenicline (3)  ·  nabiximols (2)  ·  Aspirin (1)  ·  BID protein, human (1)  ·  Celecoxib (1)  ·  Cognitive Behavioral Therapy (1)  ·  Control Groups (1)  ·  Crisis Intervention (1)  ·  Dexmedetomidine (1)  ·  Dronabinol (1)  ·  Flavoring Agents (1)  ·  Fluid Therapy (1)  ·  Gadolinium (1)

Sponsors

Yale University (4)  ·  Medical University of South Carolina (3)  ·  University of Pennsylvania (2)  ·  Wake Forest University Health Sciences (2)  ·  Alternative Research Initiative (1)  ·  Anna Stanhewicz, PhD (1)  ·  AstraZeneca (1)  ·  Columbia University (1)  ·  Hamilton Health Sciences Corporation (1)  ·  Hannah Harris (1)  ·  Jasper A. Smits (1)  ·  Johns Hopkins University (1)  ·  M.D. Anderson Cancer Center (1)  ·  Masonic Cancer Center, University of Minnesota (1)  ·  Mayo Clinic (1)

Countries

United States (29)  ·  United Kingdom (2)  ·  Canada (1)  ·  Kazakhstan (1)  ·  Pakistan (1)

Top investigators

Cara C Young, Ph.D. (1)  ·  Colleen A Hanlon, Ph.D. (1)  ·  Colleen A Hanlon, PhD (1)  ·  Dana Mowls Carroll, Ph.D., M.P.H (1)  ·  David Halpin, MD (1)  ·  Dawson Church, PhD (1)  ·  Edward C Hensel, PhD in Mechanical Engineering (1)  ·  Elise M Stevens, PhD (1)  ·  Elizabeth Oelsner, MD, MPH (1)  ·  Eric C Donny, PhD (1)  ·  Gail Gauvreau, PhD (1)  ·  Hannah M Harris, Ph.D. (1)  ·  James M Davis, MD (1)  ·  Jasper AJ Smits, Ph.D. (1)  ·  Jeffrey Stein, Ph.D. (1)

Results publications

PMID 11717401, PMID 20884658, PMID 21687919, PMID 22320954, PMID 24006963, PMID 26284723, PMID 29486753, PMID 30932386, PMID 31241286, PMID 32578165, PMID 33249458, PMID 34399137, PMID 36878389, PMID 38011129, PMID 38050181, PMID 38167206, PMID 38789642, PMID 38871445, PMID 9583654, PMID 9725117

NIH funding

K05AA014715 (1), K99DA046563 (1), P50DA019706 (1), R01DA038709 (1), R01DA038832 (1), R01DA057925 (1), R03DA047588 (1), R21DA049539 (1), R21DA053393 (1)